• Jennifer King MPH

  • Epidemiologist


    • Center for Clinical Epidemiology & Population Health
    • 1000 North Oak Ave. ML2 Marshfield, WI 54449

Education


2007:
BS, Biomedical Science, Marquette University, Milwaukee, WI
2009:
MPH, Epidemiology, Emory University, Rollins School of Public Health, Atlanta, GA

Work Experience


2007 to 2008:
Surveillance Research Assistant, Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, GA
2008 to 2008:
Summer Intern, Nebraska Department of Health and Human Services, Division of Public Health, Epidemiology Division, Lincoln, NE
2008 to 2009:
Graduate Research Assistant, Rollins School of Public Health, Hubert Department of Global Health, Rotavirus Research Group, Atlanta, GA
2009 to 2013:
Project Coordinator, Northwestern University, Feinberg School of Medicine, Division of General Internal Medicine , Chicago, IL
2013 to Present:
Epidemiologist, Marshfield Clinic Research Institute, Marshfield, WI

Statement


Jennifer King, MPH is an epidemiologist and project manager in CCEPH with a primary focus on respiratory and vaccine-preventable infections. She serves as project manager for the CDC-funded US Influenza Vaccine Effectiveness (Flu VE) Network and related clinical trials of influenza vaccine immune response. The Network has also recently been leveraged to investigate COVID-19 epidemiology. She was a co-investigator on Vaccine Safety Datalink studies including evaluations of the safety of influenza vaccination during early pregnancy. Ms. King contributes to all aspects of study planning and implementation, protocol development, operational planning, data analysis, and preparation of manuscripts and reports. In addition, she provides consultation and support for the MCRI trauma research program.

Prior to joining Marshfield Clinic in 2013, Ms. King was a project leader at Northwestern University, Feinberg School of Medicine. She directed a large, multi-site, cross-sectional study on over-the-counter pain relievers and potential interventions to reduce medication errors. During her graduate studies, she gained experience as an intern at both state and national public health agencies.

Research Interests


Infectious Diseases
Vaccine Safety
Trauma
Health Literacy
Social Epidemiology

Select Publications


  • McLean HQ, King JP, Talley P, Flannery B, Spencer S, Levine MZ,...Belongia EA. Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016. J Pediatric Infect Dis Soc. 2020 April 30; 9(2):173-180.
    PubMed ID: 30759228
  • King JP, Hanson KE, Donahue JG, Glanz JM, Klein NP, Naleway AL,...Belongia EA. Survey of influenza vaccine knowledge, attitudes, and beliefs among pregnant women in the 2016-17 season. VACCINE. 2020 February 24; 38(9):2202-2208.
    PubMed ID: 31992481
  • Belongia EA, Levine MZ, Olaiya O, Gross FL, King JP, McLean HQ, Flannery B. Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018. [published online ahead of print 2020 March 4]. VACCINE.
    PubMed ID: 32145994
  • Donahue JG, Kieke BA, King JP, Mascola MA, Shimabukuro TT, DeStefano F,...Belongia EA [including Hanson KE, McClure DL, Olaiya O.] Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15. VACCINE. 2019 October 16; 37(44):6673-6681.
    PubMed ID: 31540812
  • King JP, McLean HQ, Meece JK, Levine MZ, Spencer SM, Flannery B, Belongia EA. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season. VACCINE. 2018 February 21; 36(9):1214-1219.
    PubMed ID: 29395525
  • King JP, McLean HQ, Belongia EA. Validation of Self-Reported Influenza Vaccination in the Current and Prior Season. Influenza Other Respir Viruses.. 2018 November; 12(6):808-813.
    PubMed ID: 30028081
  • Belongia EA, King JP, Kieke BA, Pluta J, Al-Hilli A, Meece JK, Shinde V. Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults =60 Years Old. Open Forum Infect Dis.. 2018 December; 5(12):ofy316.
    PubMed ID: 30619907
  • McLean HQ, Peterson SH, King JP, Meece JK, Belongia EA. (2017 May). School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015. Influenza Other Respi Viruses. 11(3):220-229.
    PubMed ID: 27885805
  • Van Wormer JJ, King JP, Gajewski A, McLean HQ, Belongia EA. (2017 Dec). Influenza and Workplace Productivity Loss in Working Adults. J Occup Environ Med. 59(12):1135-1139.
    PubMed ID: 28759481
  • Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA,...Belongia EA. (2017 September 25). Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12. VACCINE. 35(40):5314-5322.
    PubMed ID: 28917295
  • Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ. (2016 August). Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 16(8):942-951.
    PubMed ID: 27061888
  • King JP, McCarthy DM, Serper M, Jacobson KL, Mullen RJ, Parker RM, Wolf MS. (2015 December). Variability in Acetaminophen Labeling Practices: a Missed Opportunity to Enhance Patient Safety. J Med Toxicol. 11(4):410-4..
    PubMed ID: 25697756
  • King JP, Davis TC, Bailey SC, Jacobson KL, Hedlund LA, Di Francesco L,...Wolf MS. (2011 June). Developing consumer-centered, nonprescription drug labeling a study in acetaminophen. Am J Prev Med. 40(6):593-8.
    PubMed ID: 21565649